1,877
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys

, , , , , , , , , , , , , , , , , , , , , & show all
Pages 654-669 | Received 14 Jan 2022, Accepted 28 Mar 2022, Published online: 18 Apr 2022

References

  • Smither AR, Bell-Kareem AR. Ecology of Lassa virus. Curr Top Microbiol Immunol. 2021. Berlin, Heidelberg: Springer. doi:10.1007/82_2020_231.
  • Kouadio L, Nowak K, Akoua-Koffi C, et al. Lassa virus in multimammate rats, Côte d’Ivoire, 2013. Emerg Infect Dis. 2015;21:1481–1483. DOI:10.3201/eid2108.150312.
  • Mateo M, Picard C, Sylla Y, et al. Fatal case of Lassa fever, Bangolo district, Côte d’Ivoire, 2015. Emerg Infect Dis. 2019;25:1753–1756. DOI:10.3201/eid2509.190239.
  • Safronetz D, Lopez JE, Sogoba N, et al. Detection of Lassa virus, Mali. Emerg Infect Dis. 2010;16(7):1123–1126. DOI:10.3201/eid1607.100146.
  • Whitmer SLM, Strecker T, Cadar D, et al. New lineage of Lassa virus, Togo, 2016. Emerg Infect Dis. 2018;24:599–602. DOI:10.3201/eid2403.171905.
  • Yadouleton A, Picard C, Rieger T, et al. Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus. Emerging Microbes Infect. 2020;9(1):1761–1770. DOI:10.1080/22221751.2020.1796528.
  • Monath TP, Newhouse VF, Kemp GE, et al. Lassa virus isolation from mastomys natalensis rodents during an epidemic in Sierra Leone. Science. 1974;185(4147):263–265.
  • Olayemi A, Cadar D, Magassouba N, et al. New hosts of the Lassa virus. Sci Rep. 2016;6:25280. DOI:10.1038/srep25280.
  • Kafetzopoulou LE, Pullan ST, Lemey P, et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science. 2019;363(6422):74–77. DOI:10.1126/science.aau9343.
  • McCormick JB, Fisher-Hoch SP. Lassa fever. Curr Top Microbiol Immunol. 2002;262:75–109.
  • Yun NE, Walker DH. Pathogenesis of Lassa fever. Viruses. 2012;4(10):2031–2048.
  • Mateer EJ, Huang C, Shehu NY, et al. Lassa fever-induced sensorineural hearing loss: a neglected public health and social burden. PLoS Negl Trop Dis. 2018;12:e0006187.
  • Baillet N, Reynard S, Perthame E, et al. Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques. Commun Biol. 2021;4(1):27. DOI:10.1038/s42003-020-01543-7.
  • Hensley LE, Smith MA, Geisbert JB, et al. Pathogenesis of Lassa fever in cynomolgus macaques. Virol J. 2011;8:205. DOI:10.1186/1743-422X-8-205.
  • Safronetz D, Strong JE, Feldmann F, et al. A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques. J Infect Dis. 2013;207(8):1316–1327. DOI:10.1093/infdis/jit004.
  • Stein DR, Warner BM, Audet J, et al. Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates. PLoS Pathog. 2021;17:e1009966. DOI:10.1371/journal.ppat.1009966.
  • Andersen KG, Shapiro B, Matranga C, et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell. 2015;162(4):738–750. DOI:10.1016/j.cell.2015.07.020.
  • Mateo M, Reynard S, Journeaux A, et al. A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains. Sci Transl Med. 2021;13(597). DOI:10.1126/scitranslmed.abf6348.
  • Baize S, Marianneau P, Loth P, et al. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J Virol. 2009;83:5890–5903. DOI:10.1128/JVI.01948-08.
  • Cross RW, Xu R, Matassov D, et al. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. J Clin Invest. 2020;130(1):539–551. DOI:10.1172/JCI131958.
  • Lefort V, Longueville JE, Gascuel O. SMS: smart model selection in PhyML. Mol Biol Evol. 2017;34:2422–2424.
  • Geisbert TW, Jones S, Fritz EA, et al. Development of a new vaccine for the prevention of Lassa fever. PLoS Med. 2005;2:e183. DOI:10.1371/journal.pmed.0020183.
  • Mateo M, Reynard S, Carnec X, et al. Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot. Sci Transl Med. 2019;11(512). DOI:10.1126/scitranslmed.aaw3163.
  • Gunther S, Emmerich P, Laue T, et al. Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain. Emerg Infect Dis. 2000;6(5):466–476. DOI:10.3201/eid0605.000504.
  • Atkin S, Anaraki S, Gothard P, et al. The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveill. 2009;14:19145
  • Cashman KA, Wilkinson ER, Shaia CI, et al. A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever. Hum Vaccines Immunother. 2017;13:2902–2911. DOI:10.1080/21645515.2017.1356500.
  • Okokhere P, Colubri A, Azubike C, et al. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. Lancet Infect Dis. 2018;18:684–695. DOI:10.1016/S1473-3099(18)30121-X.
  • Feldmann H, Bugany H, Mahner F, et al. Filovirus-Induced endothelial leakage triggered by infected monocytes/macrophages. J Virol. 1996;70:2208–2214. DOI:10.1128/jvi.70.4.2208-2214.1996.
  • Overbosch F, de Boer M, Veldkamp KE, et al. Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019. Eurosurveillance. 2020;25(15):2000265. DOI:10.2807/1560-7917.ES.2020.25.15.2000265.
  • Ter Meulen J, Badusche M, Kuhnt K, et al. Characterization of human CD4 + T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol. 2000;74:2186–2192. DOI:10.1128/JVI.74.5.2186-2192.2000.
  • Ter Meulen J, Badusche M, Satoguina J, et al. Old and New world arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Virology. 2004;321(1):134–143. DOI:10.1016/j.virol.2003.12.013.
  • Wolf T, Ellwanger R, Goetsch U, et al. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases. J Travel Med. 2020;27. DOI:10.1093/jtm/taaa035
  • Sahin M, Remy MM, Merkler D, et al. The Janus Kinase inhibitor ruxolitinib prevents terminal shock in a mouse model of arenavirus hemorrhagic fever. Microorganisms. 2021;9(3):564.
  • Yeleswaram S, Smith P, Burn T, et al. Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment. Clin Immunol. 2020;218:108517. DOI:10.1016/j.clim.2020.108517.
  • Safronetz D, Mire C, Rosenke K, et al. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. PLoS Negl Trop Dis. 2015;9:e0003736. DOI:10.1371/journal.pntd.0003736.
  • Salami K, Gouglas D, Schmaljohn C, et al. A review of Lassa fever vaccine candidates. Curr Opin Virol. 2019;37:105–111.
  • Schaeffer J, Carnec X, Reynard S, et al. Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells. PLoS Pathog. 2018;14:e1007430. DOI:10.1371/journal.ppat.1007430.
  • Cokelaer T, Desvillechabrol D, Legendre R, et al. ‘Sequana’: a set of snakemake NGS pipelines. J Open Source Soft. 2017;2. DOI:10.21105/joss.00352.
  • Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. Embnet. 2011;17(1).
  • Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. DOI:10.1093/bioinformatics/bts635.
  • Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.